This is relating to requesting additional clinical trials, but maybe I don’t understand?

Could you elaborate?

Edit: looks like it’s actually a request for approval for commercialization/use of the vaccine. Not sure what I was doing when I looked the first time.

And the article linked in the OP states:

"Pfizer said it will seek regulatory approval for a Lyme disease vaccine candidate despite failing a late-stage trial.

Pfizer said not enough people contracted Lyme disease to be confident in the results, but cited “strong efficacy” for its decision to move forward."

Which is sort of different wording of what the OP does still say, so, yeah, some doubt’s about it. I can see some desire to have additional studies at least.

Looks like they have a link talking about this, and someone commented that they use a service mentioned for contactless payments.

https://shkspr.mobi/blog/2025/06/contactless-payments-with-grapheneos/

I haven’t reviewed this myself as it’s not a concern for me.